Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise

Adv Prostaglandin Thromboxane Leukot Res. 1985:13:375-7.
No abstract available

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / blood
  • Acrylates / therapeutic use*
  • Angina Pectoris / drug therapy
  • Coronary Disease / blood
  • Coronary Disease / drug therapy*
  • Humans
  • Methacrylates / therapeutic use*
  • Oxidoreductases / antagonists & inhibitors*
  • Physical Exertion*
  • Platelet Aggregation / drug effects
  • Prostaglandins / blood*
  • Thromboxane B2 / blood
  • Thromboxane-A Synthase / antagonists & inhibitors*

Substances

  • Acrylates
  • Methacrylates
  • Prostaglandins
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Oxidoreductases
  • Thromboxane-A Synthase
  • ozagrel